An industry for healthy lives

Vaccines Europe represents all the major vaccine companies operating in Europe which undertake 79% of their global production and more than 50% of their global research projects in the region.

Initiatives

Access to vaccines

Immunisation is one the major public health achievements of the 20th century. Indeed, vaccination campaigns around the world have been responsible for the eradication of smallpox and have significantly reduced the burden of…
Read more….

Awareness & attitudes

Vaccination has done more to save lives and improve quality of life that any other medical intervention. According to WHO, immunisation saves between 2 and 3 million lives each year. Through effective vaccine use smallpox was eradicated…
Read more….

Influenza

Influenza, commonly called “flu”, is an infection of the respiratory tract that affects the nose, throat and the lungs characterised by high fever, severe headache, sore throat, general aches and pains, chills, weakness and…
Read more….

Immunisation throughout life

Reduced childhood mortality, increased longevity and changing birth rates are dramatically changing demography in Europe and around the world. With these changes, comes the need to extend the vision of vaccination from…
Read more….

Research & innovation

Continuous investment in vaccine research, development, and production represents a major public health strength and economic asset for the European Union (EU). While Vaccines Europe members are global in nature, the majority of their operations…
Read more….

Value of the industry

In the late 18th century, Edward Jenner, an English physician, conducted the first scientific attempt to control smallpox, a life-threatening disease that has ever since been eradicated. Over 200 hundred years later, Europe continues to be at the centre…
Read more….